Search
Close this search box.
Search
Close this search box.

Pakistan

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end

Yandex develops and open-sources Perforator, an open-source tool that can save businesses billions of dollars a year on server infrastructure

Perforator Yandex introduces Perforator, a tool that can identify and evaluate code inefficiencies across a company’s entire code base. Perforator helps developers identify the most resource-intensive sections of code and provides detailed statistics for subsequent optimization. The solution can help businesses reduce CPU resource usage by 20% annually. By leveraging

Lantronix to Debut New LM4 AI-Powered Out-of-Band Management Platform at Cisco Live

LM4 Platform Brings Affordable Management Automation to IDFs and Small Sites LM4 Out-of-Band Management Platform IRVINE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling AI Edge intelligence, will debut its new LM4 AI-powered Out-of-Band Management (OOBM)

Unlock Your Trading Edge with Axi at the 2025 Money Expo Mexico

Broker to showcase their capital allocation program, Axi Select, Manchester City memorabilia, and more SYDNEY, Feb. 04, 2025 (GLOBE NEWSWIRE) — Leading online FX and CFD broker Axi announced that it is attending this year’s Money Expo Mexico, taking place on February 26-27, 2025, at Centro Citibanamex. Event attendees will